Koyfin Home > Directory > Health Care > Amicus Therapeutics > Issuance of Common Stock

Amicus Therapeutics Issuance of Common Stock Chart (FOLD)

Amicus Therapeutics annual/quarterly Issuance of Common Stock from 2006 to 2018.
  • Amicus Therapeutics Issuance of Common Stock for the quarter ending September 09, 2018 was $1m a -718.09% decrease of -7m year over year
  • Amicus Therapeutics Issuance of Common Stock for the last 12 months ending September 09, 2018 was $314m a 17.45% increase of 55m year over year
  • Amicus Therapeutics Annual Issuance of Common Stock for 2017 was $259m a 61.40% increase of 159m from 2016
  • Amicus Therapeutics Annual Issuance of Common Stock for 2016 was $100m a -157.96% decrease of -158m from 2015
  • Amicus Therapeutics Annual Issuance of Common Stock for 2015 was $258m a 45.99% increase of 119m from 2014
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Issuance of Common Stock Data

09/2018$1m
06/2018$7m
03/2018$299m
12/2017$7m
09/2017$250m
06/2017$1m
03/2017$0m
12/2016$2m
09/2016$40m
06/2016$58m

Annual FOLD Issuance of Common Stock Data

2017$259m
2016$100m
2015$258m
2014$139m
2013$15m
2012$82m
2011$0m
2010$45m
2009$0m
2008$1m